At a glance
ClinicalIndex Comparison RecordN/ACompleted· 165 enrolled
Drug / intervention
Remimazolamdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The 90% Effective Dose (ED90) of Remimazolam Anesthesia Induction in Painless Bidirectional Endoscopy in Children: a Biased Coin up and Down Sequential Trial
In Brief
A clinical study evaluating Remimazolam for Bidirectional Endoscopy. Completed, enrolled 165 participants across 1 site.
Detailed Summary
Exploring the ED90 of remimazolam in pediatric bidirectional endoscopy at different age groups.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBidirectional Endoscopy
CountriesChina
Collaborators--
Timeline
N/ACompletedFinished
202420252026
First PostedNov 2023
Enrollment StartJan 2024
Primary CompletionApr 2024
TodayJul 2026
First PostedNov 8, 2023
Enrollment StartJan 15, 2024
Primary CompletionApr 30, 2024
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 2.6 years ago
Interventions
Remimazolamdrug
Exploring ED90 induced by remimazolam anesthesia in children of different age groups undergoing painless bidirectional endoscopy